SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue zoomed 23.56% to Rs. 4478.30 millions for the quarter ended December 2024 as compared to Rs. 3624.30 millions during the corresponding quarter last year.Net profit of the cmpany stood at Rs. 468.90 millions for the quarter ended December 2024 a decline of -32.34% from Rs. 693.00 millions  in the same quarter last year.The company reported a good operating profit of 931.40 millions compared to 292.60 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 4478.30 3624.30 23.56 12744.58 10429.27 22.20 14421.68 10724.32 34.48
Other Income 189.30 99.40 90.44 347.84 233.46 48.99 303.86 418.48 -27.39
PBIDT 931.40 292.60 218.32 2136.93 436.65 389.39 813.05 -510.65 -259.22
Interest 28.90 23.60 22.46 60.92 86.55 -29.61 104.20 93.80 11.09
PBDT 902.50 949.10 -4.91 2076.01 1030.20 101.52 132.77 -1731.09 -107.67
Depreciation 284.50 256.10 11.09 809.47 802.33 0.89 1054.58 1059.79 -0.49
PBT 618.00 693.00 -10.82 1266.54 227.87 455.82 -921.81 -2790.88 -66.97
TAX 149.10 0.00 0.00 149.10 0.00 0.00 0.00 206.12 0.00
Deferred Tax 149.10 0.00 0.00 149.10 0.00 0.00 0.00 206.12 0.00
PAT 468.90 693.00 -32.34 1117.44 227.87 390.38 -921.81 -2997.00 -69.24
Equity 140.80 140.80 0.00 140.81 140.81 0.00 140.81 140.81 0.00
PBIDTM(%) 20.80 8.07 157.62 16.77 4.19 300.48 5.64 -4.76 -218.40

Unichem Lab Share Price

350.85 4.85 (1.40%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×